Efficacy and Safety of Clearing Heat and Detoxifying Injection in the Treatment of Influenza: A Randomized, Double-Blinded, Placebo-Controlled Trial
Table 1
Demographic characteristics of the participants and clinical characteristics of influenza-infected participants.
Characteristic
Study groups
CHDI, 30 mL ()
Oseltamivir, 75 mL ()
Age, mean (SD), y
37.9 (13.9)
38.4 (14.5)
Men, number (%)
12 (50.00)
7 (31.81)
Drug used before enrollment, number (%)
0 (0)
0 (0)
Merge other disease, number (%)
0 (0)
0 (0)
Infected, number (%)
18 (75)
16 (72)
Influenza A
14
13
Influenza B
4
3
Individuals infected with influenza
()
()
Duration of illness before study, mean (SD), h
15.50 (14.00)
19.00 (13.00)
Axillary temperature, mean (SD), °C
38.66 (0.22)
38.78 (0.30)
Total symptoms severity score at enrollment, mean (SD)
20.29 (4.71)
20.35 (4.83)
CHDI: clearing heat and detoxifying injection. Influenza A virus infections were predominantly SWL; 2 infections in oseltamivir group were due to H3N2 virus.